| 000 | 01408 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250515025217.0 | ||
| 264 | 0 | _c20060929 | |
| 008 | 200609s 0 0 eng d | ||
| 022 | _a0269-2813 | ||
| 024 | 7 |
_a10.1111/j.1365-2036.2006.02923.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFabrizi, F | |
| 245 | 0 | 0 |
_aMeta-analysis: the adjuvant role of thymopentin on immunological response to hepatitis B virus vaccine in end-stage renal disease. _h[electronic resource] |
| 260 |
_bAlimentary pharmacology & therapeutics _cJun 2006 |
||
| 300 |
_a1559-66 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't; Review; Systematic Review | ||
| 650 | 0 | 4 | _aAdjuvants, Immunologic |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHepatitis B _ximmunology |
| 650 | 0 | 4 |
_aHepatitis B Vaccines _ximmunology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aKidney Failure, Chronic _ximmunology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
| 650 | 0 | 4 | _aRenal Dialysis |
| 650 | 0 | 4 |
_aThymopentin _xadministration & dosage |
| 700 | 1 | _aDixit, V | |
| 700 | 1 | _aMartin, P | |
| 773 | 0 |
_tAlimentary pharmacology & therapeutics _gvol. 23 _gno. 11 _gp. 1559-66 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1365-2036.2006.02923.x _zAvailable from publisher's website |
| 999 |
_c16296896 _d16296896 |
||